Figure 6From: Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulationsCompetition Western blot analysis with lysates from P. falciparum blood stage parasites and recombinant GMZ2, MSP3 or GLURP. Total lysates of in vitro cultivated parasites were separated by SDS-PAGE under reducing conditions and blotted onto a nitrocellulose membrane. Serum of a NMRI mouse immunized with IRIV-formulated GMZ2 was pre-incubated with or without recombinant competitor protein and subsequently added to cut strips. Immune serum was used at a dilution of 1:2000 and competitors at a concentration of 1 μg/mL.Back to article page